CoChat

Treatment of premenstrual syndrome by spironolactone: A double‐blind, placebo‐controlled study

Wang, Mingde, Hammarbäck, Stefan, Lindhe, Bengt‐Åke, Bäckström, Torbjörn · 1995 · Acta Obstetricia et Gynecologica Scandinavica
Cited by 120

The DOI matches its Crossref record.

Abstract

Background. To reevaluate whether spironolactone, a steroid receptor antagonist, is effective in improving premenstrual syndrome (PMS) in a double‐blind, placebo‐controlled cross over study. Methods. Thirty‐five women with PMS were given one tablet of 100 mg spironolactone or placebo daily from day 14 of the menstrual cycle until the first day of the following menstruation. Two pretreatment cycles were observed for diagnosis in each woman, followed by 6 treatment cycles with spironolactone and placebo applied in either the first or second 3 months. The assessment of symptoms and diagnosis of PMS were based on prospective daily self‐ratings made by the women using a validated visual analogue scale. Results. The treatment with spironolactone was associated with an improvement in PMS symptoms compared to placebo as judged by significant decrease in negative mood symptom scores (p < 0.001) and somatic symptom scores (p < 0.001). Of the individual symptoms, spironolactone significantly improved irritability, depression, feeling of swelling, breast tenderness and food craving in comparison to placebo. A lasting effect of spironolactone was observed in women started with spironolactone after cross over to placebo. Conclusions. Spironolactone appears to be an effective therapy for the negative mood changes and somatic symptoms in PMS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/00016349509021201

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 120

Metadata

Authors
Wang, M., Hammarbäck, S., Lindhe, B., & Bäckström, T.
Venue
Acta Obstetricia et Gynecologica Scandinavica
Publisher
Wiley
Published
1995-10
Volume
74
Issue
10
Pages
803-808
ISSN
  • 0001-6349 (ISSN-L)
  • 1600-0412
OpenAlex
W2118407326
Cited by
120
References
0
FWCI
0.48
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of premenstrual syndrome by spironolactone: A double‐blind, placebo‐controlled study. https://app.cochat.ai/papers/10.3109/00016349509021201
The paper
Wang, M., Hammarbäck, S., Lindhe, B., & Bäckström, T. (1995). Treatment of premenstrual syndrome by spironolactone: A double‐blind, placebo‐controlled study. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.3109/00016349509021201

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.